These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Osteocyte recruitment declines as the osteon fills in: interacting effects of osteocytic sclerostin and previous hip fracture on the size of cortical canals in the femoral neck. Power J; Doube M; van Bezooijen RL; Loveridge N; Reeve J Bone; 2012 May; 50(5):1107-14. PubMed ID: 22353552 [TBL] [Abstract][Full Text] [Related]
27. Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy. Toscani D; Bolzoni M; Ferretti M; Palumbo C; Giuliani N Front Immunol; 2018; 9():2467. PubMed ID: 30410490 [TBL] [Abstract][Full Text] [Related]
28. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice. Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631 [TBL] [Abstract][Full Text] [Related]
29. Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo. Woo SM; Rosser J; Dusevich V; Kalajzic I; Bonewald LF J Bone Miner Res; 2011 Nov; 26(11):2634-46. PubMed ID: 21735478 [TBL] [Abstract][Full Text] [Related]
30. Chronological immunolocalization of sclerostin and FGF23 in the mouse metaphyseal trabecular and cortical bone. Sakurai A; Hasegawa T; Kudo A; Shen Z; Nagai T; Abe M; Yoshida T; Hongo H; Yamamoto T; Yamamoto T; Oda K; Freitas PHL; Li M; Sano H; Amizuka N Biomed Res; 2017; 38(4):257-267. PubMed ID: 28794403 [TBL] [Abstract][Full Text] [Related]
31. Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo. Li F; Cain JD; Tombran-Tink J; Niyibizi C J Bone Miner Metab; 2019 Sep; 37(5):773-779. PubMed ID: 30607618 [TBL] [Abstract][Full Text] [Related]
32. Parathyroid hormone signaling in mature osteoblasts/osteocytes protects mice from age-related bone loss. Uda Y; Saini V; Petty CA; Alshehri M; Shi C; Spatz JM; Santos R; Newell CM; Huang TY; Kochen A; Kim JW; Constantinou CK; Saito H; Held KD; Hesse E; Pajevic PD Aging (Albany NY); 2021 Dec; 13(24):25607-25642. PubMed ID: 34968192 [TBL] [Abstract][Full Text] [Related]
33. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells. Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355 [TBL] [Abstract][Full Text] [Related]
34. Iron overload induced osteocytes apoptosis and led to bone loss in Hepcidin Ma J; Wang A; Zhang H; Liu B; Geng Y; Xu Y; Zuo G; Jia P Bone; 2022 Nov; 164():116511. PubMed ID: 35933095 [TBL] [Abstract][Full Text] [Related]
36. Twist1 Inactivation in Dmp1-Expressing Cells Increases Bone Mass but Does Not Affect the Anabolic Response to Sclerostin Neutralization. Lewis KJ; Choi RB; Pemberton EZ; Bullock WA; Firulli AB; Robling AG Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505764 [TBL] [Abstract][Full Text] [Related]
37. Osteocytes. Rupp M; Merboth F; Daghma DE; Biehl C; El Khassawna T; Heiß C Z Orthop Unfall; 2019 Apr; 157(2):154-163. PubMed ID: 30366349 [TBL] [Abstract][Full Text] [Related]
38. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2. Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439 [TBL] [Abstract][Full Text] [Related]
39. A review of osteocyte function and the emerging importance of sclerostin. Compton JT; Lee FY J Bone Joint Surg Am; 2014 Oct; 96(19):1659-68. PubMed ID: 25274791 [TBL] [Abstract][Full Text] [Related]